Drug Side Effects
Search
RETIFANLIMAB-DLWR
RETIFANLIMAB-DLWR
was reported 72 times
These side effects are most commonly reported by patients taking RETIFANLIMAB-DLWR:
#
Side effect
Count
0
OFF LABEL USE
25
1
DISEASE PROGRESSION
11
2
ANAL SQUAMOUS CELL CARCINOMA
6
3
ANAL CANCER
5
4
DEATH
4
5
MALIGNANT NEOPLASM PROGRESSION
4
6
NAUSEA
4
7
ANAEMIA
3
8
CONDITION AGGRAVATED
3
9
DECREASED APPETITE
3
10
MALAISE
3
11
NEUROPATHY PERIPHERAL
3
12
PRODUCT DOSE OMISSION ISSUE
3
13
THROMBOCYTOPENIA
3
14
GENERAL PHYSICAL HEALTH DETERIORATION
2
15
INTESTINAL OBSTRUCTION
2
16
METASTASES TO LIVER
2
17
NASOPHARYNGITIS
2
18
NEUTROPENIA
2
19
PLATELET COUNT DECREASED
2
20
THERAPY CESSATION
2
21
TREATMENT NONCOMPLIANCE
2
22
ALOPECIA
1
23
ANAL CANCER RECURRENT
1
24
ARTHRALGIA
1
25
ASTHENIA
1
26
AUTOIMMUNE THYROIDITIS
1
27
BLINDNESS
1
28
BONE PAIN
1
29
BREAST CANCER
1
30
CELLULITIS
1
31
COLOSTOMY INFECTION
1
32
COVID-19
1
33
COVID-19 PNEUMONIA
1
34
DEPRESSION
1
35
DIABETES MELLITUS
1
36
DIARRHOEA
1
37
DRUG ERUPTION
1
38
DRUG HYPERSENSITIVITY
1
39
DYSSTASIA
1
40
ELECTROLYTE IMBALANCE
1
41
FATIGUE
1
42
FEELING ABNORMAL
1
43
GAIT DISTURBANCE
1
44
GASTROINTESTINAL DISORDER
1
45
GRAVES^ DISEASE
1
46
HEPATIC ENZYME INCREASED
1
47
HOSPITALISATION
1
48
HYPERSENSITIVITY
1
49
HYPERTHYROIDISM
1
50
HYPOAESTHESIA
1
51
HYPOAESTHESIA ORAL
1
52
HYPOGLYCAEMIA
1
53
ILLNESS
1
54
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION
1
55
INFUSION RELATED REACTION
1
56
INFUSION SITE INFECTION
1
57
JOINT LOCK
1
58
MOBILITY DECREASED
1
59
NEUROENDOCRINE CARCINOMA OF THE SKIN
1
60
NO ADVERSE EVENT
1
61
OEDEMA PERIPHERAL
1
62
PLATELET COUNT ABNORMAL
1
63
POLYNEUROPATHY
1
64
PRODUCT STORAGE ERROR
1
65
PRODUCT USE IN UNAPPROVED INDICATION
1
66
PSORIASIS
1
67
PSYCHOTIC DISORDER
1
68
SECONDARY ADRENOCORTICAL INSUFFICIENCY
1
69
SKIN ULCER
1
70
STRESS
1
71
THYROIDITIS
1
72
URINARY TRACT INFECTION
1
73
URTICARIA
1
74
VOMITING
1
75
WEIGHT DECREASED
1